BIOTW

Biotech Acquisition Company Warrant
BIOTW

Overview Fund Activity
Delisted

BIOTW was delisted on the 2nd of February, 2023.

Back to rankings

48 hedge funds and large institutions have $4.21M invested in Biotech Acquisition Company Warrant in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
-4
Holders Change %
-7.69%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
10
Reduced
4
Closed
9
Calls
$5.72M
Puts
–
Net Calls
+$5.72M
Net Calls Change
-$26K

Top Buyers

1
BFM
Boothbay Fund Management
New York
+$571K
2
HIM
HGC Investment Management
Ontario, Canada
+$202K
3
RA
Ramius Advisors
New York
+$51K
4
PAMP
Polar Asset Management Partners
Ontario, Canada
+$38.3K
5
SCM
Shaolin Capital Management
Florida
+$9K

Top Sellers

1
SRCM
Sage Rock Capital Management
New York
-$69K
2
MF
Magnetar Financial
Illinois
-$49K
3
PC
Periscope Capital
Ontario, Canada
-$40K
4
KSCM
Kamunting Street Capital Management
Florida
-$38K
5
AC
Aristeia Capital
Connecticut
-$29.8K
Name Holding Trade Value Shares
Change 		Shares
Change %
KSCM
51
Kamunting Street Capital Management
Florida
– -$38K -158,962 Closed
CAC
52
Cowen and Company
New York
– -$8K -34,299 Closed
ICMH
53
Integrity Capital Management (HK)
Hong Kong
– -$8K -33,267 Closed
YCM
54
Yakira Capital Management
Connecticut
– -$6K -26,908 Closed
COPPSERS
55
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$6K -25,000 Closed
Susquehanna International Group
56
Susquehanna International Group
Pennsylvania
– -$4K -15,354 Closed
1 2
3